Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  537 results for ""INTERFERON alpha""

Your Filters

Filter by : Subject Subject : interleukin-2
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Recombinant porcine Interferon-α and Interleukin-2 fusion protein (rPoIFNα+IL-2) shows potent anti-pseudorabies virus activity in vitro and in vivo.

  • Authors : Zhao K; College of Veterinary Medicine, Hebei Agricultural University, Baoding, China; Hebei Key Laboratory of Analysis and Control of Zoonotic Pathogenic Microorganism, Hebei Agricultural University, Baoding, China.

Subjects: Interleukin-2*/Interleukin-2*/Interleukin-2*/pharmacology ; Herpesvirus 1, Suid*/Herpesvirus 1, Suid*/Herpesvirus 1, Suid*/genetics; Swine

  • Source: Veterinary microbiology [Vet Microbiol] 2023 Apr; Vol. 279, pp. 109678. Date of Electronic Publication: 2023 Feb 07.Publisher: Elsevier Scientific Pub. Co Country of Publication: Netherlands NLM ID: 7705469 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

A novel model based on qAnti-HBc and conventional biomarkers for identifying significant liver injury among CHB patients with ALT ≤ ULN.

  • Authors : Feng M; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; Liu K

Subjects: Interleukin-17* ; Interleukin-2*; Alanine Transaminase

  • Source: Antiviral research [Antiviral Res] 2022 Jun; Vol. 202, pp. 105315. Date of Electronic Publication: 2022 Apr 06.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Restoration of HBV-specific CD8 + T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy.

  • Authors : Wang D; Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medicine and Medical Center, University of Science and Technology of China, Hefei, Anhui, 230001, China.; Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui, 230001, China.

Subjects: Hepatitis B, Chronic/Hepatitis B, Chronic/Hepatitis B, Chronic/*drug therapy ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*administration & dosage ; Interleukin-2/Interleukin-2/Interleukin-2/*administration & dosage

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2021 Nov 05; Vol. 6 (1), pp. 376. Date of Electronic Publication: 2021 Nov 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort.

  • Authors : Bastholt L; Department of Clinical Oncology, Odense University Hospital, Odense, Denmark. Electronic address: .; Svane IM

Subjects: Immunotherapy*/Immunotherapy*/Immunotherapy*/adverse effects; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Jul; Vol. 115, pp. 61-67. Date of Electronic Publication: 2019 May 17.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Combined use of interferon alpha-1b, interleukin-2, and thalidomide to reverse the AML1-ETO fusion gene in acute myeloid leukemia.

  • Authors : Mi R; The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, 450008, China.; Chen L

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Core Binding Factor Alpha 2 Subunit/Core Binding Factor Alpha 2 Subunit/Core Binding Factor Alpha 2 Subunit/*genetics ; Immunologic Factors/Immunologic Factors/Immunologic Factors/*therapeutic use

  • Source: Annals of hematology [Ann Hematol] 2021 Oct; Vol. 100 (10), pp. 2593-2601. Date of Electronic Publication: 2021 Jul 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer.

  • Authors : Thibodeaux SR; The Graduate School of Biomedical Sciences, University of Texas Health San Antonio, Texas.; Department of Medicine, University of Texas Health San Antonio, Texas.

Subjects: Lymphocyte Depletion* ; T-Lymphocytes, Regulatory*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jul 01; Vol. 27 (13), pp. 3661-3673. Date of Electronic Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Synergistic Mechanism of Interferon alpha-1b, Interleukin-2 and Thalidomide for Immune Regulation in Patients with Acute Myeloid Leukemia].

  • Authors : Mi RH; Cancer Hospital Affiliated to Zhengzhou University/Henan Cancer Hospital, Zhengzhou 450008, Henan Province, China.; Chen L

Subjects: Interleukin-2* ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy; CD8-Positive T-Lymphocytes

  • Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Feb; Vol. 29 (1), pp. 26-31.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.

  • Authors : Perazella MA; Section of Nephrology, Department of Medicine, Yale University, New Haven, Connecticut; and .

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*chemically induced ; Immunotherapy/Immunotherapy/Immunotherapy/*adverse effects ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*adverse effects

  • Source: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2018 Aug; Vol. 29 (8), pp. 2039-2052. Date of Electronic Publication: 2018 Jun 29.Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Engineering cytokines and cytokine circuits.

  • Authors : Li AW; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; Cell Design Institute, University of California, San Francisco, CA, USA.

Subjects: Cell Engineering* ; Cytotoxicity, Immunologic* ; Protein Engineering*

  • Source: Science (New York, N.Y.) [Science] 2020 Nov 27; Vol. 370 (6520), pp. 1034-1035.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[Combination of interferon alpha-1b, interleukin-2 and thalidomide as maintenance therapy on acute myeloid leukemia patients with negative minimal residual disease].

  • Authors : Chen L; The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou 450008, China.; Li GP

Subjects: Interleukin-2*/Interleukin-2*/Interleukin-2*/therapeutic use ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy ; Thalidomide*/Thalidomide*/Thalidomide*/therapeutic use

  • Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2020 Sep 14; Vol. 41 (9), pp. 766-769.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium: Print ISSN: 0253-2727

Record details

Read More Add to Saved list
×
  • 1-10 of  537 results for ""INTERFERON alpha""